Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/29/25 18:14 | 1/28/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Ganot Ilan | MA | D | 5 | S.d | -17 | 5.75 | 0 | -3 | 130 | M | ||||||||||||||||
1/13/25 18:51 | 1/10/25 | SLDB | Health | BioPrd | Biological Products, (No Diag | Tan Kevin | MA | O | CFO,Trea | 2 | S.d | -48 | 6.01 | 0 | -8 | 25 | D | |||||||||||||||
12/4/24 17:34 | 12/3/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Hanrahan Jessie | MA | O | Chief Re | 2 | S.d | -39 | 4.15 | 0 | -9 | 14 | D | |||||||||||||||
12/4/24 17:27 | 12/3/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Cumbo Alexander | MA | DO | P,CEO | 2 | S.d | -95 | 4.14 | 0 | -23 | 38 | D | |||||||||||||||
12/4/24 17:04 | 12/3/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Howton David T | MA | O | COO | 2 | S.d | -43 | 4.15 | 0 | -10 | 16 | D | |||||||||||||||
12/4/24 16:42 | 12/3/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Herzich Paul | MA | O | CTO | 2 | S.d | -24 | 4.14 | 0 | -6 | 12 | D | |||||||||||||||
10/22/24 16:05 | 10/21/24 | SLDB | Health | BioPrd | Biological Products, (No Diag | Brooks Gabriel | MA | O | Chief Me | 1 | S.d | -19 | 6.50 | 0 | -3 | 11 | D | |||||||||||||||
12/5/23 14:30 | 12/4/23 | SLDB | Health | BioPrd | Biological Products, (No Diag | Marlowe Jennifer | MA | O | CSO | 1 | S.d | -14 | 2.77 | 0 | -5 | 7 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |